Founder mutations in <it>BRCA1/2 </it>are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
<p>Abstract</p> <p>Background</p> <p>Relatives of <it>BRCA1 </it>and <it>BRCA2 </it>mutation carriers have long been proposed by epidemiological studies to have an increased risk of developing prostate cancer. In the Ashkenazi Jewish (AJ) populat...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2003-08-01
|
Series: | BMC Medical Genetics |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2350/4/7 |